Fluent Essays

N2920 Acute Pathophysiology II Student Learning Outcome 3: Utilize best available evidence and informatics to guide decision making Semester 5 Competency C: Identify the rationale for the protection of human subjects in the conduct of research. ARTICLE FINDING & SUBMISSION · THIS IS AN INDIVIDUAL ASSIGNMENT · Find an article related to any disease or disorder included in this semester. · Article should be an informational article (ideas include: research article, evidence-based article, continuing education units (CEUs) article, peer-reviewed article). · Submit the article to the drop box for approval and points. Due Oct. 6th , 2359 RUBRIC Article Grading Criteria Satisfactory/ Unsatisfactory Locate a Research Article & Submit Article · Article is from a Nursing or Allied Health journal · Article is current (no more than 5 years old) · Journal is English language journal · Article is applicable to your chosen disease · Article authored by nurses and/or MDs · Content of article provides expansion of knowledge towards disease of topic. Ideas of Nurse Journals: · American Journal of Critical Care American Association of Critical-Care Nurses · American Journal of Public Health American Public Health Association · American Nurse Today HealthCom Media · Clinical Journal of Oncology Nursing Oncology Nursing Society · Critical Care Medicine Lippincott Williams & Wilkins · Diabetes Care American Diabetes Association, Inc. · Evidence-Based Nursing BMJ Publishing Group American Journal of Nursing NURSING 2019 · Journal of the American Geriatrics Society Blackwell Publishing · Journal of Hospice and Palliative Nursing Lippincott Williams & Wilkins · Journal for Nurse Practitioners Elsevier · Journal of Pediatric Health Care Mosby, Inc. · Newborn and Infant Nursing Reviews Elsevier · Nursing Economics Jannetti Publications, Inc. · OJIN: The Online Journal of Issues in Nursing American Nurses Association · Oncology Nursing Forum Oncology Nursing Society RESEARCH ARTICLE SUMMATION PAPER *20 Points* · Using your approved article and your Porth, Ricci, or Brunner textbook, write a 2-3 page paper (not including title page and reference page) on a pathophysiological disease or disorder · Your article will drive the content of your paper. Due Nov. 18th, 2359 RUBRIC PAPER Part 2 Grading Criteria Points APA Style (6 points) (7th ed.) · Title page correct · Double spaced, correct margins, page numbers, & font · In-text citations correct · Reference page correct · 1 point · 1 point · 2 points · 2 point Paper structure (5 points) · Grammar and punctuation correct with no spelling errors · Paper includes an introduction, body, and conclusion · Paper includes at least one level-one header · Paper is organized, clear, and easy to follow · 2 points · 1 point · 1 point · 1 point Paper content (9 points) · Definition of the disease/disorder · Explanation of the pathophysiology of the disease/disorder · Summarization of the article correlating its main topic(s) · Description of how humans were used in the research. If none in article, brief paragraph describing ethical treatment expectations. · Porth Book is used as one of the references · Paper is 2-3 pages in length · 2 points · 2 points · 2 point · 1 point · 1 point · 1 point Point Loss · Paper exceeds 3 pages · Paper states name of student · Turn it in score 25 – 35\% · Turn it in score 36 – 45\% · > 45\% · -1 · -1 · -1 · -2 Paper must be re-written; late penalty Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes Diabetes Care 2020;43:2768–2775 | https://doi.org/10.2337/dc20-0187 OBJECTIVE This study assessed whether a single diabetic ketoacidosis (DKA) episode is associated with cognitive declines in children with newly diagnosed type 1 diabetes and whether the same is true in children who had previously been diagnosed after accounting for variations in glycemic control and other relevant factors. RESEARCH DESIGN AND METHODS Weprospectivelyenrolled758children,6–18yearsold,whopresentedwithDKAina randomized multisite clinical trial evaluating intravenous fluid protocols for DKA treatment. DKA was moderate/severe in 430 children and mild in 328 children. A total of 392 children with DKA had new onset of type 1 diabetes, and the rest were previously diagnosed. Neurocognitive assessment occurred 2–6 months after the DKA episode. A comparison group of 376 children with type 1 diabetes, but no DKA exposure, was also enrolled. RESULTS Among all patients, moderate/severe DKA was associated with lower intelligence quotient (IQ) (b 5 20.12, P < 0.001), item-color recall (b 5 20.08, P 5 0.010), and forward digit span (b 5 20.06, P 5 0.04). Among newly diagnosed patients, moderate/severe DKA was associated with lower item-color recall (b 5 20.08, P 5 0.04). Among previously diagnosed patients, repeated DKA exposure and higher HbA1c were independently associated with lower IQ (b 5 20.10 and b 5 20.09, respectively, P < 0.01) and higher HbA1c was associated with lower item-color recall (b 5 20.10, P 5 0.007) after hypoglycemia, diabetes duration, and socioeconomic status were accounted for. CONCLUSIONS A single DKA episode is associated with subtle memory declines soon after type 1 diabetes diagnosis. Sizable IQ declines are detectable in children with known diabetes, suggesting that DKA effects may be exacerbated in children with chronic exposure to hyperglycemia. Diabetic ketoacidosis (DKA) is a common complication of type 1 diabetes (1). Of children with new onset of type 1 diabetes, 25–40\% present with DKA (2). In established patients, DKA may be the consequence of poor adherence to insulin regimens, illness, or malfunction of diabetes care equipment (e.g., insulin pumps) (2). Brain injury has long been recognized as an uncommon, but serious, complication of 1Department of Psychology, University of Cal- ifornia, Davis, Davis, CA 2Center for Mind and Brain, University of Cal- ifornia, Davis, Davis, CA 3Department of Emergency Medicine, UC Davis Health, UC Davis School of Medicine, Sacramento, CA 4Department of Pediatrics, UC Davis Health, UC Davis School of Medicine, Sacramento, CA 5Division of Emergency Medicine, Department of Pediatrics, Children’s Hospital Colorado, Univer- sity of Colorado School of Medicine, University of Colorado Denver, Aurora, CO 6Division of Emergency Medicine, Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Penn- sylvania, Philadelphia, PA 7Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 8Division of Emergency Medicine, Department of Pediatrics, Nationwide Children’s Hospital, The Ohio State University College of Medicine, Co- lumbus, OH 9Departments of Emergency Medicine and Pedi- atrics, Rhode Island Hospital, The Warren Alpert Medical School, Brown University, Providence, RI Simona Ghetti,1,2 Nathan Kuppermann,3,4 Arleta Rewers,5 Sage R. Myers,6 Jeff E. Schunk,7 Michael J. Stoner,8 Aris Garro,9 Kimberly S. Quayle,10 Kathleen M. Brown,11 Jennifer L. Trainor,12 Leah Tzimenatos,3 Andrew D. DePiero,13 Julie K. McManemy,14 Lise E. Nigrovic,15 Maria Y. Kwok,16 Clinton S. Perry III,2,17 Cody S. Olsen,7 T. Charles Casper,7 and Nicole S. Glaser,4 for the Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group* 2768 Diabetes Care Volume 43, November 2020 P A T H O P H Y S IO LO G Y /C O M P LI C A T IO N S https://doi.org/10.2337/dc20-0187 http://crossmark.crossref.org/dialog/?doi=10.2337/dc20-0187&domain=pdf&date_stamp=2020-10-03 DKA (3,4). Recent studies, however, sug- gest that subtle brain injury occurs even among children with no obvious neuro- logical symptoms during DKA (5,6). Re- ports document that DKA is associated with alterations in memory, attention, verbal intelligence quotient (IQ) (7–12), and changes in brain microstructure (10–12). Despite this evidence, several ques- tions remain. First, it is unclear whether a single DKA episode results in lasting cognitive declines that are detectable shortly after the DKA episode in children with new onset of type 1 diabetes. Most studies reporting lower cognitive func- tioning after a single DKA episode were retrospective, included children previ- ously diagnosed with type 1 diabetes, or documented deficits in comparison withcontrolsubjectswith nodiagnosisof type 1 diabetes (7–9). One small pro- spective study of newly diagnosed pa- tients found that those who experienced DKA(compared with a sampleof children with type 1 diabetes and no histories of DKA) showed subtle mental status and memory deficits between 48 h and 5 days after DKA (12). These group differ- ences no longer persisted, however, 1 month and 6 months after diagnosis (12). Among children who experienced DKA, the severity of the DKA episode and alterations in brain microstructure de- tected during DKA were associated with worse cognitive functioning 6 months after diagnosis (12). It is possible that variations in DKA severity predict cogni- tive functioning only among children who experienced DKA, without resulting in overall differences between children with and without DKA histories. How- ever, these findings suggest that large- scale studies are necessary to fully assess the neurocognitive effects of DKA in children with newly diagnosed type 1 diabetes. Second, reports of DKA-related cogni- tive deficits in children previously diag- nosed with type 1 diabetes raise the question of whether these deficits may be more extensive or become more ro- bust over time if DKA occurs in the setting of long-standing hyperglycemia (9). In a longitudinal study of children previously diagnosed with type 1 diabetes (36\% with one DKA episode), DKA exposure was associated with lower IQ 18 months later (13). However, these studies have not been able to fully account for important correlatesofDKAoccurrenceandseverity, including glycemic variability (e.g., hyper- glycemia, hypoglycemia) (9), which are also associated with cognitive outcomes, and socioeconomic status (SES), which is generally associated with access to care and cognitive outcomes (14). In the current study, we examined whether the severity of a single DKA episode was associated with cognitive deficits in children newly diagnosed with type1diabetes.Inaddition,weexamined whether DKA severity of a single episode and/or repeated episodes of DKA are associated with more general cognitive deficits in children with previously di- agnosed type 1 diabetes, after account- ing for measures of glycemic control, such as HbA1c and severe hypoglycemic events, duration of type 1 diabetes, and SES. RESEARCH DESIGN AND METHODS Children with type 1 diabetes between the ages of 6 and 18 years were recruited from sites participating in the Pediatric Emer- gency Care Applied Research Network (PECARN) Fluid Therapies Under Investiga- tion in DKA (FLUID) randomized controlled trial (15,16). The study was approved by the InstitutionalReviewBoardateachsite,and written informed consent was obtained from each patient’s parents or guardians. ThePECARNFLUIDtrialcomparedfour fluidrehydrationprotocolscapturingvar- iations in protocols currently used in the U.S. totreat DKA inchildren(15). DKA was defined by 1) blood glucose concentration .300 mg/dL and 2) venous pH ,7.25 or serum bicarbonate concentration ,15 mmol/L.Exclusioncriteriahavepreviously been described (16) and included condi- tions unrelated to DKA that affect mental status or cognitive abilities and/or sub- stantial treatment for DKA prior to trans- fer to the study centers. All patients’ medical records were reviewed by the child’s primary endocrinologist to deter- mine whether there were previous epi- sodes of DKA or severe hypoglycemia. Parents and guardians were also queried about any hospital admissions occurring at hospitals other than the study site. If any such episodes were recalled, the child’s endocrinologist reviewed these episodes with the family to verify that the admission was for DKA. For the pres- ent report, children were excluded if they experienced clinically apparent DKA- related brain injury (15) or could not return within 6 months for cognitive test- ing. Finally, children younger than 6 years of age were also excluded because the cognitive testing procedures used in the current study were not appropriate for younger children. Children with type 1 diabetes, but no histories of DKA, were recruited from the pediatric diabetes clinics at the partici- pating PECARN centers. Absence of DKA at diagnosis and between diagnosis and follow-up, and episodes of severe hypo- glycemia, were verified through medical record review and confirmed by the patient’s endocrinologist and family. 10Division of Emergency Medicine, Department of Pediatrics, St. Louis Children’s Hospital, Wash- ington University School of Medicine in St. Louis, St. Louis, MO 11Division of Emergency Medicine, Department of Pediatrics, Children’s National Medical Center, The School of Medicine & Health Sciences, The George Washington University, Washington, DC 12Division of Emergency Medicine, Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 13Division of Emergency Medicine, Nemours/Alfred I. duPont Hospital for Children, Sidney Kimmel Medical College,ThomasJeffersonUniversity,Philadelphia,PA 14Division of Emergency Medicine, Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 15Division of Emergency Medicine, Department of Pediatrics, BostonChildren’s Hospital, Harvard Medical School, Boston, MA 16Division of Emergency Medicine, Department of Pediatrics, New York Presbyterian Morgan Stanley Children’s Hospital, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 17Department of Psychology, Tufts University, Medford, MA Corresponding author: Simona Ghetti, [email protected] ucdavis.edu Received 26 January 2020 and accepted 18 August 2020 This article contains supplementary material online at https://doi.org/10.2337/figshare.12824396. *A list of members of the Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group can be found in the supple- mentary material online. © 2020 by the American Diabetes Association. Readersmayuse this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More infor- mationisavailableathttps://www.diabetesjournals .org/content/license. care.diabetesjournals.org Ghetti and Associates 2769 mailto:[email protected] mailto:[email protected] https://doi.org/10.2337/figshare.12824396 https://www.diabetesjournals.org/content/license https://www.diabetesjournals.org/content/license http://care.diabetesjournals.org Recruitment was targeted to maintain approximately equal proportions of pa- tients with new onset of type 1 diabetes and patients with known diagnoses of type 1 diabetes in the DKA and non-DKA groups. Patients with DKA returned between 2 and 6 months after hospital discharge for neurocognitive assessment. Patients with type 1 diabetes but no DKA histories were scheduled at their earliest conve- nience. The assessment for both the DKA and non-DKA groups was resched- uled if children had either hypoglycemia (glucose ,70 mg/dL) or hyperglycemia (glucose.350mg/dL)withketosis(urine dipstick with moderate or large ketones) at the time of the visit. Outcomes A comprehensive neurocognitive assess- ment included the following: 1) color and spatial memory tasks evaluating long- term memory for pictures and associa- tion with the correct color background or spatial location with which children were initially presented (range 0–1); 2) Wechsler Abbreviated Scale of Intelli- gence, yielding an IQ score (range 65– 160) (17); and 3) digit span forward and backward task (range 0–18), evaluating short-term and working memory. Higher scorescorrespondto betterperformance. We used these measures as in our previous research (7,15,18) (see supplementary materials for detailed description). Statistical Analyses We described the characteristics of pa- tients with new onset of type 1 diabetes and those previously diagnosed with and without histories of DKA using relative frequencies for categorical characteris- tics and means and SDs for continuous characteristics. We tested for differences as a function of DKA status using likeli- hood ratio tests and ANOVA tests for categorical and continuous characteris- tics, respectively. We used x2 and Wil- coxon rank sum tests to determine whether participants with DKA histories who completed the neurocognitive as- sessments differed from those who were lost to follow-up. To include all patients with observed outcomesintheanalyses,weusedchained regression equations for imputation of missing data (19). Ten imputations were used, and results were combined using standard methods (20–22) (Supplementary Table 1). Multiple imputation was used for predictors so that all patients with outcomes were included in the statisti- cal analyses; imputed values were not used foroutcome measures. Patients with moderate/severe DKA and mild DKA and without DKA histories were compared on all of the outcome measures with use of mixed linear models. All models included random terms for the enrolling clinical center. Initially, models were applied to all patients and fit to item-color and item- spacememory tasks, IQ, and forward and backward digit span scores separately. The focal independent variable was DKA status,whichwasbasedonvenouspH(or serum bicarbonate concentration in pa- tients without a measured pH at pre- sentation) inpatientswith DKA and was a numeric scale defined as 2, moderate/ severe (pH #7.19 or bicarbonate con- centration #9 mmol/L); 1, mild (pH between 7.20 and 7.25 or bicarbonate between 10 and 15 mmol/L) (23); or 0, no DKA history (pH .7.25 or bicarbonate .15 mmol/L for patients with new onset of type 1 diabetes and no recorded DKA episodes for patients with established type 1 diabetes). We also included sex, SES (measured by maternal parental education on a numeric scale: 0 5 high school/GED or less, 1 5 some college/vocational school, 2 5 college degree or more), diabetes history (new onset vs. previously diagnosed), and his- tory of severe hypoglycemic episodes (one or more vs. none). Age was included in models for item-color memory, item- space memory, and digit span scores but not IQ, which is normalized by age. In- dependent variables were tested for an association with use of type III F tests and a significance level of 0.05. We calculated 95\% CIs for standardized re- gression parameters. We subsequently applied these mod- els separately to patients with new onset and those previously diagnosed with type 1 diabetes. We report results only for outcomes showing associations with DKA status in the initial models including all patients. In models pertaining to pre- viously diagnosed patients, we addition- ally included 12-month average HbA1c, diabetes duration, and whether DKA had previously been experienced as indepen- dent variables. Again, F tests were used to identify significant associations, and 95\% CIs were calculated for standardized regression coefficients. Analyses were performed using SAS software (version 9.4; SAS Institute, Cary, NC). In exploratory analyses restricted to children with new onset of type 1 di- abetes, we examined the correlation be- tween pH at the time of diagnosis and IQ using Spearman correlation coefficients. In other exploratory analyses restricted to previously diagnosed patients, we in- cluded 1) the interaction between DKA severity and SES in the regression models described earlier, given differences in SES across DKA status groups in these pa- tients, and the possibility that variability in SES was confounded with or obscured DKA status effects, and 2) the interaction between DKA exposure and age at onset of type 1 diabetes to explore whether the effects of DKA were stronger in children with onset of type 1 diabetes in early childhood. RESULTS A description of patient enrollment can be found in a flow diagram (Supplementary Fig. 1). Between February 2011 and Sep- tember 2016, 1,249 children with DKA were enrolled in the PECARN FLUID trial and were eligible for neurocognitive follow- up; of these, 901 (72.1\%) returned for follow-up, and 758 (84.1\%) of patients who returned were retained for the pres- ent report based on eligibility criteria. Of these children (Table 1), 430 (56.7\%) ex- perienced moderate or severe DKA and 328 mild DKA (43.3\%); 392 (51.7\%) had new onset of diabetes, and 366 were previously diagnosed. Among previously diagnosed patients, 270 (73.8\%) had at least one DKA episode prior to participat- ing.ChildrenwithDKAexposurewhowere lost to follow-up were older, more likely to be previously diagnosed, and more likely to have higher mean HbA1c levels than those who completed the neurocognitive assessments (Supplementary Table 2). In addition, we assessed 376 children with type 1 diabetes and no DKA histories; 199 (52.9\%) of these had new onset of type 1 diabetes. Among newly diagnosed patients, there were no significant differences in demographic variables as a function of DKA status (Table 1). Among the children with previously diagnosed type 1 diabe- tes,differencesasafunctionofDKAstatus were found in several demographic and diabetes-related variables (Table 1). 2770 Pediatric Diabetic Ketoacidosis and Cognition Diabetes Care Volume 43, November 2020 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 https://doi.org/10.2337/figshare.12824396 The first analysis included all partic- ipants (i.e., both newly diagnosed and previously diagnosed patients) and com- paredcognitiveoutcomesin childrenwith moderate or severe DKA, mild DKA, or no DKA history. Additional variables in the model included age at testing, sex, SES, experience of severe hypoglycemia, and whetherchildren werenewly orpreviously diagnosed. DKA status was associated with lower scores in overall IQ, memory for item-color associations, and forward digit span recall (Table 2). Backward digit span recallandmemoryforitem-spacerelations did not differ between moderate/severe DKA, mild DKA, and non-DKA groups (Supplementary Table 3). Children with pre- viously diagnosed type 1 diabetes showed lower performance compared with chil- dren with new onset in the item-color associations and overall IQ (Table 2). Table 1—Baseline characteristics of the enrolled patients by DKA status Non-DKA Mild DKA Moderate/severe DKA P*(N 5 376) (N 5 328) (N 5 430) New onset, N (\%) 199 (52.9) 198 (60.4) 194 (45.1) ,0.001 Male, N (\%) 108 (54.3) 94 (47.5) 92 (47.4) 0.29 Age at testing, mean (SD) 11.3 (3.16) 11.5 (2.79) 11.6 (2.85) 0.52 Age at onset of diabetes, mean (SD) 10.7 (3.17) 10.8 (2.79) 10.9 (2.89) 0.90 Glucose at neurocognitive testing, mean (SD) 164.4 (68.78) 163.0 (73.57) 167.0 (77.93) 0.86 Any hypoglycemic episodes prior to testing, N (\%) 0 (0.0) 19 (9.6) 11 (5.7) ** SES, N (\%)† 0.74 High school/GED or less 48 (24.1) 47 (23.9) 57 (29.4) Some college/vocational school 54 (27.0) 52 (26.3) 50 (25.8) College degree or more 97 (48.9) 98 (49.7) 87 (44.8) Previously diagnosed, N (\%) 177 (47.1) 130 (39.6) 236 (54.9) Male, N (\%) 87 (49.2) 58 (44.6) 106 (44.9) 0.64 Age at testing, mean (SD) 12.2 (3.18) 13.1 (2.83) 14.0 (2.56) ,0.001 Age at onset of diabetes, mean (SD) 8.3 (3.46) 6.7 (3.55) 7.8 (3.66) ,0.001 Duration of diabetes in years, mean (SD) 3.4 (3.33) 5.9 (3.43) 5.7 (3.33) ,0.001 Glucose at neurocognitive testing, mean (SD) 206.4 (87.30) 247.7 (103.07) 230.9 (97.37) ,0.001 Any hypoglycemic episodes prior to testing, N (\%) 12 (6.9) 35 (27.1) 48 (20.4) ,0.001 One or more additional DKA episodes, N (\%) 0 (0.0) 101 (77.5) 169 (71.5) ** 12-month average HbA1c result, mean (SD) 8.3 (1.34) 10.2 (1.91) 10.6 (1.75) ,0.001 SES, N (\%)† 0.003 High school/GED or less 32 (18.0) 47 (36.4) 100 (42.5) Some college/vocational school 48 (27.2) 46 (35.6) 75 (31.6) College degree or more 97 (54.8) 36 (28.0) 61 (25.9) *P values are from likelihood ratio x2 tests for categorical characteristics [those with N (\%)] and ANOVA F tests for continuous characteristics [those with mean(SD)],usingmethodsforcombiningresultsacrossmultipleimputeddatasets.**Pvalueswerenotcalculatedduetodesign-imposedrelationshipswith DKA status. †Maternal education if documented. If not, imputed using paternal education and household income in a multinomial regression model. Table 2—Regression models applied to all patients: standardized regression coefficients and 95\% CIs*† and adjusted means*† and raw means by DKA status Color task IQ Digit span recall: forward Coefficient (95\% CI) P Coefficient (95\% CI) P Coefficient (95\% CI) P DKA status‡ 20.08 (20.13, 20.02) 0.010 20.12 (20.19, 20.06) ,0.001 20.06 (20.12, 20.00) 0.04 Male 20.05 (20.10, 0.00) 0.07 0.01 (20.04, 0.07) 0.67 20.00 (20.06, 0.05) 0.88 Age 0.47 (0.41, 0.53) ,0.001 Not estimated 0.41 (0.35, 0.47) ,0.001 Previously diagnosed# 20.07 (20.13, 20.01) 0.02 20.08 (20.14, 20.03) 0.004 20.05 (20.11, 0.01) 0.10 SES§ 0.10 (0.04, 0.16) ,0.001 0.32 (0.26, 0.38) ,0.001 0.12 (0.06, 0.17) ,0.001 Previous severe hypoglycemia 0.01 (20.05, 0.07) 0.72 20.03 (20.09, 0.03) 0.30 0.00 (20.05, 0.06) 0.96 Color task IQ Digit span recall: forward DKA status Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) No DKA 0.50 (0.012) 0.50 (0.180) 104.6 (1.15) 107.3 (13.95) 8.5 (0.14) 8.6 (2.25) Mild DKA 0.48 (0.010) 0.49 (0.170) 102.6 (1.02) 103.7 (13.46) 8.4 (0.12) 8.2 (2.11) Moderate/severe DKA 0.47 (0.011) 0.49 (0.168) 100.7 (1.12) 101.2 (12.31) 8.2 (0.13) 8.5 (2.06) *Regressioncoefficientsarestandardizedandrepresentthemeanchangeinoutcomeassociatedwitha1-SDchangeinacontinuousfactororthechange associated with that level (male, previously diagnosed, previous severe hypoglycemia) for binary variables. Note that the estimated change for the reference value (female, new onset, no hypoglycemia) is 21 times the coefficient. Adjusted means average over sex, previous diagnosis, and previous severe hypoglycemia and assume age 5 12 and SES 5 1. †Random effect of site included in each model. ‡DKA status is on a numeric scale: 0 5 no DKA, 15mildDKA,25moderate/severeDKA.#Previouslydiagnosed:05newlydiagnosedpatients and1 5previouslydiagnosedpatients,allowingforthe comparison of these two groups. §SES is indicated by maternal education and is on a numeric scale: 0 5 high school/GED or less, 1 5 some college/ vocational school, 2 5 college degree or more; when data were missing, income and paternal education were used to impute SES. care.diabetesjournals.org Ghetti and Associates 2771 https://doi.org/10.2337/figshare.12824396 http://care.diabetesjournals.org The next set of analyses examined per- formance separately for patients with new onset of type 1 diabetes and those pre- viously diagnosed. We limited these anal- yses to the outcomes that showed an overall effect of DKA status in the previous analysis, namely, item-color memory, IQ, and forward digit span. Patients With Newly Diagnosed Type 1 Diabetes The regression models including newly diagnosed patients revealed significant differences as a function of DKA status at presentation for item-color association memory but not for IQ and forward digit span (Table 3). In exploratory analyses restricted to patients who presented with DKA, lower venous pH was associ- ated with lower IQ (r 5 0.18, P 5 0.001). This correlation retained its significance when we controlled for sex, SES, and glucose level at diagnosis of DKA and at testing (r 5 0.16, P 5 0.003). Patients With Previously Diagnosed Type 1 Diabetes The models examining previously diag- nosed patients revealed that DKA status was not related to any of the cognitive outcomes but that greater number of previous DKA episodes and higher HbA1c were independently and negatively re- lated to IQ (Table 3). HbA1c was also negatively related to item-color memory (Table 3). However, DKA status was as- sociated with both mean HbA1c and SES among previously diagnosed patients in bivariable analyses (Table 1), limiting our ability to isolate the unique effects of DKA among patients with poor glycemic control. Furthermore, the associations between DKA status and SES among previously diagnosed patients (Table 1) and SES and neurocognitive outcomes (Tables 2 and 3) raise the question of whether preexisting differences among patient groups may account for or ob- scure differences as a function of DKA status. To address this question, we conducted exploratory analyses in which an interaction term involving DKA status and SES was added to the regression model for previously diagnosed patients. These analyses revealed a significant in- teractioneffect(Supplementary Table4), such that DKA status was associated with lower IQ among children with higher SES (Fig. 1), whereas patients with lower SES exhibited lower IQ regardless of DKA Table 3—Regression models applied separately to patients with new-onset and previously diagnosed diabetes New-onset patients Color task IQ Digit span recall: forward Coefficient (95\% CI) P Coefficient (95\% CI) P Coefficient (95\% CI) P DKA status‡ 20.08 (20.16, 20.00) 0.04 20.06 (20.14, 0.02) 0.13 20.03 (20.11, 0.05) 0.44 Male 20.06 (20.13, 0.02) 0.14 0.02 (20.06, 0.09) 0.63 0.03 (20.04, 0.11) 0.37 Age 0.45 (0.37, 0.53) ,0.001 Not estimated 0.39 (0.31, 0.47) ,0.001 SES§ 0.11 (0.04, 0.19) 0.003 0.34 (0.26, 0.42) ,0.001 0.12 (0.04, 0.19) 0.003 Previous severe hypoglycemia 0.03 (20.08, 0.14) 0.61 20.07 (20.18, 0.04) 0.21 20.06 (20.17, 0.05) 0.28 Color task IQ Digit span recall: forward DKA status Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) No DKA 0.52 (0.019) 0.49 (0.175) 103.9 (1.63) 106.9 (14.18) 8.3 (0.23) 8.5 (2.25) Mild DKA 0.50 (0.016) 0.50 (0.159) 102.9 (1.43) 106.5 (13.15) 8.3 (0.20) 8.2 (2.06) Moderate/severe DKA 0.48 (0.017) 0.47 (0.171) 101.9 (1.53) 103.9 (12.18) 8.2 (0.21) 8.4 (2.09) Color task IQ Digit span recall: forward Previously diagnosed patients Coefficient (95\% CI) P Coefficient (95\% CI) P Coefficient (95\% CI) P DKA status‡ 20.02 (20.12, 0.08) 0.66 20.08 (20.18, 0.02) 0.14 20.08 (20.18, 0.01) 0.10 Male 20.04 (20.12, 0.04) 0.36 20.00 (20.08, 0.07) 0.94 20.04 (20.12, 0.04) 0.30 Age 0.52 (0.42, 0.62) ,0.001 Not estimated 0.41 (0.32, 0.51) ,0.001 SES§ 0.06 (20.02, 0.15) 0.16 0.27 (0.18, 0.35) ,0.001 0.12 (0.04, 0.21) 0.005 Previous severe hypoglycemia 0.01 (20.06, 0.09) 0.77 0.03 (20.04, 0.10) 0.45 0.03 (20.04, 0.10) 0.47 Mean HbA1c 20.10 (20.17, 20.03) 0.007 20.09 (20.16, 20.02) 0.008 0.03 (20.04, 0.09) 0.45 Diabetes duration 20.00 (20.09, 0.09) .0.99 20.03 (20.12, 0.05) 0.42 0.02 (20.07, 0.11) 0.62 Previous DKA episodes 20.01 (20.09, 0.07) 0.80 20.10 (20.18, 20.03) 0.009 20.04 (20.12, 0.04) 0.35 Color task IQ Digit span recall: forward DKA status Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) Adjusted mean (SE) Mean (SD) No DKA 0.47 (0.018) 0.51 (0.185) 103.0 (1.46) 107.6 (13.71) 8.5 (0.20) 8.7 (2.25) Mild DKA 0.46 (0.013) 0.47 (0.185) 101.8 (1.14) 99.2 (12.78) 8.3 (0.14) 8.3 (2.18) Moderate/severe DKA 0.46 (0.015) 0.51 (0.164) 100.6 (1.34) 98.9 (11.99) 8.0 (0.17) 8.6 (2.03) Data shown are regression coefficients and 95\% CIs and adjusted means and raw means as a function of DKA status (random effect of site included in each model). Regression coefficients are standardized and represent the mean change in outcome associated with a 1-SD change in a continuous factor or the changeassociatedwiththatlevel(male,previousseverehypoglycemia)forbinaryvariables.Notethattheestimatedchangeforthereferencevalue(female and no hypoglycemia) is 21 times the coefficient. Adjusted means are conditional on applicable covariates as follows: average sex and previous severe hypoglycemia,age512,SES51,meanHbA1c59.6\%,diabetesduration55years,andonetotwopreviousDKAepisodes.‡DKAstatusisonanumericscale: 0 5 no DKA, 1 5 mild DKA, 2 5 moderate/severe DKA. §SES is indicated bymaternaleducation and is on a numeric scale: 0 5 high school/GED or less, 1 5 some college/vocational school, 2 5 college degree or more; when data were missing, income and paternal education were used to impute SES. 2772 Pediatric Diabetic Ketoacidosis and Cognition Diabetes Care Volume 43, November 2020 https://doi.org/10.2337/figshare.12824396 status. Finally, the broad range of age of onset of type 1 diabetes in this group and evidence that early age of onset may result in worse cognitive outcomes (7) motivatedtheexaminationofinteraction effects between age of onset and DKA exposure. We found an interaction …